QQQ   354.42 (-1.89%)
AAPL   171.85 (-1.09%)
MSFT   312.59 (-2.86%)
META   300.03 (-2.21%)
GOOGL   132.48 (-1.26%)
AMZN   124.70 (-3.68%)
TSLA   247.72 (-1.54%)
NVDA   435.88 (-2.67%)
NIO   8.65 (-1.59%)
BABA   84.38 (-2.48%)
AMD   99.93 (-3.23%)
T   14.71 (+0.27%)
F   12.04 (-2.19%)
MU   67.99 (+0.04%)
CGC   0.69 (-5.83%)
GE   107.46 (-1.22%)
DIS   79.66 (-2.46%)
AMC   8.05 (-1.23%)
PFE   33.90 (-0.12%)
PYPL   57.59 (-1.66%)
NFLX   374.46 (-1.54%)
QQQ   354.42 (-1.89%)
AAPL   171.85 (-1.09%)
MSFT   312.59 (-2.86%)
META   300.03 (-2.21%)
GOOGL   132.48 (-1.26%)
AMZN   124.70 (-3.68%)
TSLA   247.72 (-1.54%)
NVDA   435.88 (-2.67%)
NIO   8.65 (-1.59%)
BABA   84.38 (-2.48%)
AMD   99.93 (-3.23%)
T   14.71 (+0.27%)
F   12.04 (-2.19%)
MU   67.99 (+0.04%)
CGC   0.69 (-5.83%)
GE   107.46 (-1.22%)
DIS   79.66 (-2.46%)
AMC   8.05 (-1.23%)
PFE   33.90 (-0.12%)
PYPL   57.59 (-1.66%)
NFLX   374.46 (-1.54%)
QQQ   354.42 (-1.89%)
AAPL   171.85 (-1.09%)
MSFT   312.59 (-2.86%)
META   300.03 (-2.21%)
GOOGL   132.48 (-1.26%)
AMZN   124.70 (-3.68%)
TSLA   247.72 (-1.54%)
NVDA   435.88 (-2.67%)
NIO   8.65 (-1.59%)
BABA   84.38 (-2.48%)
AMD   99.93 (-3.23%)
T   14.71 (+0.27%)
F   12.04 (-2.19%)
MU   67.99 (+0.04%)
CGC   0.69 (-5.83%)
GE   107.46 (-1.22%)
DIS   79.66 (-2.46%)
AMC   8.05 (-1.23%)
PFE   33.90 (-0.12%)
PYPL   57.59 (-1.66%)
NFLX   374.46 (-1.54%)
QQQ   354.42 (-1.89%)
AAPL   171.85 (-1.09%)
MSFT   312.59 (-2.86%)
META   300.03 (-2.21%)
GOOGL   132.48 (-1.26%)
AMZN   124.70 (-3.68%)
TSLA   247.72 (-1.54%)
NVDA   435.88 (-2.67%)
NIO   8.65 (-1.59%)
BABA   84.38 (-2.48%)
AMD   99.93 (-3.23%)
T   14.71 (+0.27%)
F   12.04 (-2.19%)
MU   67.99 (+0.04%)
CGC   0.69 (-5.83%)
GE   107.46 (-1.22%)
DIS   79.66 (-2.46%)
AMC   8.05 (-1.23%)
PFE   33.90 (-0.12%)
PYPL   57.59 (-1.66%)
NFLX   374.46 (-1.54%)

Inspire Medical Systems (INSP) Stock Forecast, Price & News

$181.27
-13.49 (-6.93%)
(As of 01:51 PM ET)
Compare
Today's Range
$181.27
$193.74
50-Day Range
$185.07
$291.01
52-Week Range
$159.62
$330.00
Volume
359,288 shs
Average Volume
425,479 shs
Market Capitalization
$5.32 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$345.08

Inspire Medical Systems MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
90.4% Upside
$345.08 Price Target
Short Interest
Healthy
4.02% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.66
Upright™ Environmental Score
News Sentiment
1.20mentions of Inspire Medical Systems in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$822,494 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.76) to ($0.45) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.85 out of 5 stars

Medical Sector

64th out of 976 stocks

Surgical & Medical Instruments Industry

12th out of 99 stocks


INSP stock logo

About Inspire Medical Systems (NYSE:INSP) Stock

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

INSP Price History

INSP Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
InspireSemi Announces Final Closing of Non-Brokered Private Placement
The Latest Analyst Ratings for Inspire Medical Systems
See More Headlines
Receive INSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inspire Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

INSP Company Calendar

Last Earnings
8/01/2023
Today
10/03/2023
Next Earnings (Estimated)
11/07/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
755
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$345.08
High Stock Price Forecast
$380.00
Low Stock Price Forecast
$308.00
Forecasted Upside/Downside
+77.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
11 Analysts

Profitability

Net Income
$-44,880,000.00
Pretax Margin
-7.66%

Debt

Sales & Book Value

Annual Sales
$407.86 million
Book Value
$17.17 per share

Miscellaneous

Free Float
28,016,000
Market Cap
$5.71 billion
Optionable
Optionable
Beta
1.42
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives

  • Mr. Timothy P. HerbertMr. Timothy P. Herbert (Age 60)
    CEO, Pres & Director
    Comp: $1.35M
  • Mr. Richard J. BuchholzMr. Richard J. Buchholz (Age 55)
    Chief Financial Officer
    Comp: $683.2k
  • Mr. Philip J. EbelingMr. Philip J. Ebeling (Age 52)
    Chief Operating Officer
    Comp: $696.13k
  • Mr. John C. RondoniMr. John C. Rondoni (Age 43)
    Chief Technology Officer
    Comp: $576.72k
  • Mr. Randall A. Ban (Age 58)
    Chief Commercial Officer
    Comp: $759.23k
  • Dr. Charisse Y. Sparks FAAOS (Age 60)
    M.D., Chief Medical Officer
    Comp: $21.88k
  • Ms. Ezgi Yagci
    VP of Investor Relations
  • Mr. Bryan K. Phillips (Age 52)
    Sr. VP, Gen. Counsel, Chief Compliance Officer & Corp. Sec.
  • Mr. Martin A. Abrams
    VP of Marketing & Customer Experience
  • Mr. Steven L. JandrichMr. Steven L. Jandrich (Age 56)
    VP of HR













INSP Stock - Frequently Asked Questions

Should I buy or sell Inspire Medical Systems stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inspire Medical Systems in the last twelve months. There are currently 11 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" INSP shares.
View INSP analyst ratings
or view top-rated stocks.

What is Inspire Medical Systems' stock price forecast for 2023?

11 Wall Street research analysts have issued 12-month price objectives for Inspire Medical Systems' shares. Their INSP share price forecasts range from $308.00 to $380.00. On average, they anticipate the company's stock price to reach $345.08 in the next year. This suggests a possible upside of 77.2% from the stock's current price.
View analysts price targets for INSP
or view top-rated stocks among Wall Street analysts.

How have INSP shares performed in 2023?

Inspire Medical Systems' stock was trading at $251.88 on January 1st, 2023. Since then, INSP shares have decreased by 22.7% and is now trading at $194.7750.
View the best growth stocks for 2023 here
.

Are investors shorting Inspire Medical Systems?

Inspire Medical Systems saw a increase in short interest in September. As of September 15th, there was short interest totaling 1,180,000 shares, an increase of 14.6% from the August 31st total of 1,030,000 shares. Based on an average daily volume of 512,100 shares, the short-interest ratio is currently 2.3 days.
View Inspire Medical Systems' Short Interest
.

When is Inspire Medical Systems' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 7th 2023.
View our INSP earnings forecast
.

How were Inspire Medical Systems' earnings last quarter?

Inspire Medical Systems, Inc. (NYSE:INSP) issued its quarterly earnings data on Tuesday, August, 1st. The company reported ($0.41) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.51) by $0.10. The company earned $151.09 million during the quarter, compared to the consensus estimate of $136.47 million. Inspire Medical Systems had a negative trailing twelve-month return on equity of 8.21% and a negative net margin of 7.81%. The business's quarterly revenue was up 65.3% on a year-over-year basis. During the same quarter last year, the company earned ($0.53) EPS.

What guidance has Inspire Medical Systems issued on next quarter's earnings?

Inspire Medical Systems issued an update on its FY 2023 earnings guidance on Tuesday, August, 1st. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $600.00 million-$610.00 million, compared to the consensus revenue estimate of $589.63 million.

What is Tim Herbert's approval rating as Inspire Medical Systems' CEO?

2 employees have rated Inspire Medical Systems Chief Executive Officer Tim Herbert on Glassdoor.com. Tim Herbert has an approval rating of 100% among the company's employees. This puts Tim Herbert in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inspire Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inspire Medical Systems investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), Cisco Systems (CSCO), Bank of America (BAC), DocuSign (DOCU), Pfizer (PFE), Block (SQ), Zynga (ZNGA), CrowdStrike (CRWD) and Johnson & Johnson (JNJ).

When did Inspire Medical Systems IPO?

(INSP) raised $75 million in an initial public offering on Thursday, May 3rd 2018. The company issued 5,000,000 shares at a price of $14.00-$16.00 per share. BofA Merrill Lynch and Goldman Sachs acted as the underwriters for the IPO and Guggenheim Securities, Stifel and Wells Fargo Securities were co-managers.

What is Inspire Medical Systems' stock symbol?

Inspire Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "INSP."

How do I buy shares of Inspire Medical Systems?

Shares of INSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inspire Medical Systems' stock price today?

One share of INSP stock can currently be purchased for approximately $194.78.

How much money does Inspire Medical Systems make?

Inspire Medical Systems (NYSE:INSP) has a market capitalization of $5.71 billion and generates $407.86 million in revenue each year. The company earns $-44,880,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Inspire Medical Systems have?

The company employs 755 workers across the globe.

How can I contact Inspire Medical Systems?

Inspire Medical Systems' mailing address is 5500 WAYZATA BLVD SUITE 1600, GOLDEN VALLEY MN, 55416. The official website for the company is www.inspiresleep.com. The company can be reached via phone at (844) 672-4357 or via email at inspire@lifesciadvisors.com.

This page (NYSE:INSP) was last updated on 10/3/2023 by MarketBeat.com Staff

My Account -